1. Medtech Insight
  2. >>Device Area

Promise Of Pigs: Kidney Still Functioning A Month After Xenotransplantation

 
• By Brian Bossetta

More than a month after surgeons at NYU Langone Health transplanted a pig kidney into a human being, the animal organ is still working. Surgeons say this is the longest a gene-edited pig kidney has functioned in a human body.

PIG 2 HUMAN
• Source: Shutterstock

On 14 July, surgeons at NYU Langone Health successfully transplanted a pig kidney into a neurologically dead man whose heartbeat was maintained by a generator.

More than 32 days later, the pig kidney continues to function. The hospital says that this represents the longest a pig kidney has worked in a human, as well as...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Surgery

More from Device Area

FDLI: Clinical Labs Face Uncertainty After Texas Court’s LDT Ruling

 
• By Elizabeth Orr

A Texas court's decision against US FDA regulation of lab-developed tests (LDTs) has introduced new uncertainties for clinical labs. Industry stakeholders are now worried about potential future regulations while also managing existing compliance requirements. Recent conference discussions underscored the complexities of FDA oversight.

Data Finds Capillary Blood Is A Reliable Alternative To Venous Blood For Routine Testing

 
• By Natasha Barrow

A study from Babson Diagnostics published in the peer-reviewed Journal of Applied Laboratory Medicine showed that capillary blood sample volume issues can overcome historical challenges, such as poor quality, through a technique called assay miniaturization.

First Alzheimer’s Disease Diagnostic Blood Test Cleared By FDA

 
• By Natasha Barrow

Fujirebio Diagnostics' Alzheimer's disease test, Lumipulse G pTau217/ß-Amyloid 1-42 Plasma Ratio, has been cleared by the US FDA.